Replies to post #2170 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s pro forma cash @3/31/22=$353.3M—a decrease of $24.4M since 12/31/21 (#msg-167844185).

The $353.3M figure above consists of: $311.1M of net current assets on the 3/31/22 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001177648/000095017022008483/enta-20220331.htm#consolidated_balance_sheets ); and $42.2M of marketable securities on the 3/31/22 balance sheet designated as long-term (e.g. bonds with a time to maturity greater than one year).